-

Agilent Named One of Singapore’s Best Employers

Company rises in rank from last year

SINGAPORE--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a leading Singapore-based newspaper. Specifically, Agilent is ranked among the top 100 companies and fifth out of eight in the Drugs & Biotechnology category.

“This year, Agilent Singapore is among the top 100 positions compared to our 108th ranking last year, so we’ve continued to excel—even during COVID,” said Woai-Sheng Chow, Agilent Singapore Vice President and General Manager, Global Instrument Manufacturing. “We are enormously proud of our employees.”

Rankings were determined on the results of an extensive independent survey conducted by the newspaper and Statista, a global research firm. The survey included more than 9,000 employees working at companies with more than 200 people. Employees were consulted anonymously through several online panels and through The Straits Times website. In total, more than 200,000 recommendations were evaluated, based on two distinct criteria. The first was a “direct recommendation,” an employee’s willingness to recommend their company to friends and family. The second was an “indirect recommendation,” an employee’s evaluation of other employers in their respective industries.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom.

Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Media Contact
Tom Beermann
Agilent Technologies
+1.408.553.2914
tom.beermann@agilent.com

Media Contact
Soo-Chun Tan
Agilent Technologies - Singapore
+65 6276 2622
soo-chun.tan@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Summary
Agilent Technologies announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row.
Release Versions

Contacts

Media Contact
Tom Beermann
Agilent Technologies
+1.408.553.2914
tom.beermann@agilent.com

Media Contact
Soo-Chun Tan
Agilent Technologies - Singapore
+65 6276 2622
soo-chun.tan@agilent.com

More News From Agilent Technologies Inc.

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to aid in identifying patients with esophageal or gastroesophageal junction (GEJ) carcinoma who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy. PD-L1 IHC 22C3 pharmDx, Code SK006, is the only FDA-approved companion diagnostic indica...

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas. Agilent will highlight expanded biomarker testing capabilities, continued progress in digital pathology adoption, and the evolving role of the Dako Omnis family of instruments as a founda...

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company’s expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing so...
Back to Newsroom